$CELC
Celcuity Inc. Stock $celc

$celc Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222022400 Filed on August 12, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.022M	$1.233M	$811.3K
YoY Change	59.88%	115.06%	44.87%
% of Gross Profit
Research & Development	$9.622M	$8.368M	$6.696M
YoY Change	93.96%	-35.98%	199.43%
% of Gross Profit
Depreciation & Amortization	$53.54K	$52.45K	$55.99K
YoY Change	-15.83%	-31.53%	-43.0%
% of Gross Profit
Operating Expenses	$10.64M	$9.601M	$7.508M
YoY Change	90.07%	-29.63%	168.92%
Operating Profit	-$10.64M	-$9.601M	-$7.508M
YoY Change	90.07%	-29.63%	168.92%
Interest Expense	$537.7K	$455.4K	-$426.8K
YoY Change	-225.78%	16.43%	-1778600.0%
% of Operating Profit
Other Income/Expense, Net	-$250.2K	-$359.8K	$0.00
YoY Change	-41.48%	-7.6%	-100.0%
Pretax Income	-$10.89M	-$9.961M	-$7.934M
YoY Change	80.74%	-29.02%	184.22%
Income Tax
% Of Pretax Income
Net Earnings	-$10.89M	-$9.961M	-$7.934M
YoY Change	80.74%	-29.02%	184.22%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.75	-$0.67	-$0.53
Diluted Earnings Per Share	-$729.3K	-$667.1K	-$531.9K
COMMON SHARES
Basic Shares Outstanding	14.94M shares	14.93M shares	14.92M shares
Diluted Shares Outstanding	14.94M shares	14.93M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$57.48M	$66.91M	$78.30M
YoY Change	-36.39%	60.69%	124.09%
Cash & Equivalents	$57.48M	$66.91M	$78.30M
Short-Term Investments
Other Short-Term Assets	$6.949M	$4.957M	$955.4K
YoY Change	1412.85%	1072.18%	61.93%
Inventory
Prepaid Expenses	$6.578M	$4.602M
Receivables
Other Receivables		$95.30K
Total Short-Term Assets	$64.69M	$71.96M	$79.44M
YoY Change	-29.05%	70.32%	122.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$302.0K	$238.6K	$486.0K
YoY Change	-53.9%	-42.51%	4.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$597.5K	$387.4K	$486.0K
YoY Change	-8.79%	-30.56%	-25.58%
TOTAL ASSETS
Total Short-Term Assets	$64.69M	$71.96M	$79.44M
Total Long-Term Assets	$597.5K	$387.4K	$486.0K
Total Assets	$65.29M	$72.35M	$79.93M
YoY Change	-28.91%	69.01%	119.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.168M	$2.305M	$2.139M
YoY Change	81.41%	256.09%	572.28%
Accrued Expenses	$3.278M	$1.683M	$1.406M
YoY Change	206.3%	130.69%	112.71%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$3.920K	$5.380K	$5.860K
YoY Change	-32.88%	-7.72%	-41.4%
Total Short-Term Liabilities	$6.645M	$4.150M	$3.551M
YoY Change	135.43%	170.12%	203.35%
LONG-TERM LIABILITIES
Long-Term Debt	$15.01M	$15.01M	$14.82M
YoY Change	4.03%	5.43%	148140.0%
Other Long-Term Liabilities	$107.8K	$0.00	$15.33K
YoY Change	-1.0%		-23.35%
Total Long-Term Liabilities	$15.12M	$15.01M	$14.84M
YoY Change	3.99%	5.43%	49364.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.645M	$4.150M	$3.551M
Total Long-Term Liabilities	$15.12M	$15.01M	$14.84M
Total Liabilities	$21.77M	$19.16M	$18.39M
YoY Change	25.36%	21.47%	1442.13%
SHAREHOLDERS EQUITY
Retained Earnings	-$84.72M	-$73.82M
YoY Change
Common Stock	$14.94K	$14.94K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$43.53M	$53.19M	$61.54M
YoY Change
Total Liabilities & Shareholders Equity	$65.29M	$72.35M	$79.93M
YoY Change	-28.91%	69.01%	119.79%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$10.89M	-$9.961M	-$7.934M
YoY Change	80.74%	-29.02%	184.22%
Depreciation, Depletion And Amortization	$53.54K	$52.45K	$55.99K
YoY Change	-15.83%	-31.53%	-43.0%
Cash From Operating Activities	-$9.307M	-$11.29M	-$5.933M
YoY Change	129.87%	48.17%	135.3%
INVESTING ACTIVITIES
Capital Expenditures	-$12.10K	-$22.98K	-$11.64K
YoY Change	-13.94%	-17.63%	-137.64%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$12.10K	-$22.98K	-$11.64K
YoY Change	-13.94%	-16.13%	-61.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-108.2K	-72.51K	-46.29K
YoY Change	-100.2%	-100.51%	-100.18%
NET CHANGE
Cash From Operating Activities	-9.307M	-11.29M	-5.933M
Cash From Investing Activities	-12.10K	-22.98K	-11.64K
Cash From Financing Activities	-108.2K	-72.51K	-46.29K
Net Change In Cash	-9.427M	-11.38M	-5.991M
YoY Change	-119.35%	-269.9%	-125.71%
FREE CASH FLOW
Cash From Operating Activities	-$9.307M	-$11.29M	-$5.933M
Capital Expenditures	-$12.10K	-$22.98K	-$11.64K
Free Cash Flow	-$9.295M	-$11.27M	-$5.921M
YoY Change	130.37%	48.41%	131.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001603454
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q2	CELC	Loss On Sale Of Fixed Assets LossOnSaleOfFixedAssets		usd
CY2021Q2	CELC	Loss On Sale Of Fixed Assets LossOnSaleOfFixedAssets		usd
	CELC	Loss On Sale Of Fixed Assets LossOnSaleOfFixedAssets		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	CELC	Issuance Of Common Stock Licensing Agreement IssuanceOfCommonStockLicensingAgreement		usd
	CELC	Loss On Disposition Of Assets LossOnDispositionOfAssets		usd
	CELC	Increase Decrease In Payroll Tax Receivables IncreaseDecreaseInPayrollTaxReceivables		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	CELC	Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts		usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
	CELC	Gross Proceeds From An Atm Offering GrossProceedsFromAnAtmOffering		usd
	CELC	Offering And Registration Statement Costs Included In Accrued Expenses OfferingAndRegistrationStatementCostsIncludedInAccruedExpenses		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2022Q2	CELC	Lessee Operating Lease Liability Amount Representing Services LesseeOperatingLeaseLiabilityAmountRepresentingServices		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38207
	dei	Entity Registrant Name EntityRegistrantName	CELCUITY INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-2863566
	dei	Entity Address Address Line1 EntityAddressAddressLine1	16305 36th Avenue North; Suite 100
	dei	Entity Address City Or Town EntityAddressCityOrTown	Minneapolis
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55446
	dei	City Area Code CityAreaCode	(763)
	dei	Local Phone Number LocalPhoneNumber	392-0767
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	CELC
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14941334	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66910824	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	84286381	usd
CY2022Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	22009	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	22009	usd
CY2022Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	332824	usd
CY2021Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	22144	usd
CY2022Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	95300	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	298764	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4601874	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	722677	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	71962831	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	85351975	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	238629	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	312444	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	148727	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	241901	usd
CY2022Q2	us-gaap	Assets Assets	72350187	usd
CY2021Q4	us-gaap	Assets Assets	85906320	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2304543	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1507099	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	5379	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	5850	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	156769	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	189858	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1683305	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	802893	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4149996	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2505700	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2449	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	61771	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	15011460	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	14625923	usd
CY2022Q2	us-gaap	Liabilities Liabilities	19161456	usd
CY2021Q4	us-gaap	Liabilities Liabilities	17195843	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14941334	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14941334	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14918887	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14918887	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	14941	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	14919	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	126995610	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	124622405	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-73821820	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55926847	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	53188731	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	68710477	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	72350187	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	85906320	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8367687	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13070108	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15064000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15306451	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1233040	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	573360	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2044332	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1128787	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	9600727	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	13643468	usd
	us-gaap	Operating Expenses OperatingExpenses	17108332	usd
	us-gaap	Operating Expenses OperatingExpenses	16435238	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9600727	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-13643468	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17108332	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-16435238	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	455445	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	391187	usd
	us-gaap	Interest Expense InterestExpense	890446	usd
	us-gaap	Interest Expense InterestExpense	391210	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	95646	usd
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1803	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	103805	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2191	usd
	CELC	Loss On Sale Of Fixed Assets LossOnSaleOfFixedAssets	263	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-359799	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-389384	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-786641	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-389282	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9960526	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14032852	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17894973	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16824520	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-9960526	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14032852	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17894973	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16824520	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7414	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7934447	usd
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.42
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14930538	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12610917	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14923900	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11845758	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	68710477	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	756271	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	61539715	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1519459	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	80541	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9542	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-9960526	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	53188731	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11702270	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	449098	usd
CY2021Q1	CELC	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	11257	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	25768493	usd
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	38962	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	3868	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-2791668	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	35174544	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	540317	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	25817	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	36859	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	289839	usd
CY2021Q2	CELC	Stock Issued During Period Value Issuance Of Common Stock Licensing Agreement StockIssuedDuringPeriodValueIssuanceOfCommonStockLicensingAgreement	5000000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14032852	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	27034524	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17894973	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16824520	usd
	us-gaap	Depreciation Depreciation	108436	usd
	us-gaap	Depreciation Depreciation	176597	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2275730	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	989415	usd
	CELC	Issuance Of Common Stock Licensing Agreement IssuanceOfCommonStockLicensingAgreement	5000000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	179539	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	81571	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	205998	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	93397	usd
	CELC	Loss On Disposition Of Assets LossOnDispositionOfAssets	263	usd
	CELC	Increase Decrease In Payroll Tax Receivables IncreaseDecreaseInPayrollTaxReceivables	-203464	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3879197	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-37496	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	705145	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	438018	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	875412	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-124940	usd
	CELC	Increase Decrease In Non Cash Operating Lease Expense IncreaseDecreaseInNonCashOperatingLeaseExpense	-1686	usd
	CELC	Increase Decrease In Non Cash Operating Lease Expense IncreaseDecreaseInNonCashOperatingLeaseExpense	-6550	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17222132	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10139253	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34621	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	57897	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	500	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-34621	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-57397	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	11257	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	16956	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	36859	usd
	CELC	Proceeds From Employee Stock Purchases ProceedsFromEmployeeStockPurchases	80541	usd
	CELC	Proceeds From Employee Stock Purchases ProceedsFromEmployeeStockPurchases	25817	usd
	CELC	Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts	25768493	usd
CY2021Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	652061	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	14347939	usd
	CELC	Gross Proceeds From An Atm Offering GrossProceedsFromAnAtmOffering	38962	usd
	CELC	Payments For Registration Statement Costs PaymentsForRegistrationStatementCosts	213381	usd
	CELC	Payments For Registration Statement Costs PaymentsForRegistrationStatementCosts	29065	usd
	CELC	Payments For Finance Leases PaymentsForFinanceLeases	2920	usd
	CELC	Payments For Finance Leases PaymentsForFinanceLeases	2900	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-118804	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40197362	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-17375557	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	30000712	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	84286381	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11637911	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	66910824	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41638623	usd
	us-gaap	Interest Paid Net InterestPaidNet	504909	usd
	us-gaap	Interest Paid Net InterestPaidNet	216242	usd
	CELC	Offering And Registration Statement Costs Included In Accounts Payable OfferingAndRegistrationStatementCostsIncludedInAccountsPayable	100422	usd
	CELC	Offering And Registration Statement Costs Included In Accounts Payable OfferingAndRegistrationStatementCostsIncludedInAccountsPayable	96111	usd
	CELC	Offering And Registration Statement Costs Included In Accrued Expenses OfferingAndRegistrationStatementCostsIncludedInAccruedExpenses	5000	usd
	us-gaap	Stock Issued1 StockIssued1	964839	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_z7vwbjgzaH6l" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_znPqJSvOvBFe">Accounting Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management uses estimates and assumptions in preparing these unaudited condensed financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could differ from those estimates and the difference could be material. Significant items subject to such estimates and assumptions include the valuation of stock-based compensation and prepaid or accrued clinical trial costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zPvVRq9IKg8l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zn6TDuB6znc8">Risks and Uncertainties</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is subject to risks common to companies in the development stage including, but not limited to, dependency on, the clinical and commercial success of its initial drug product, gedatolisib, the clinical and commercial success of its diagnostic tests, ability to obtain regulatory approval of its drug product, gedatolisib, ability to obtain regulatory approval of its diagnostic tests, the need for substantial additional financing to achieve its goals, uncertainty of broad adoption of its approved products, if any, by physicians and consumers, and significant competition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2020Q3	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	197211	usd
CY2021Q3	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	193517	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	148727	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	156769	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	156769	usd
CY2022Q2	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	28932	usd
CY2022Q2	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	23628	usd
CY2022Q2	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	5304	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	5379	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	5379	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	102119	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	3627	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	68080	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	3023	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	170199	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	6650	usd
CY2022Q2	CELC	Present Value Discount PresentValueDiscount	-13430	usd
CY2022Q2	CELC	Present Value Discounts PresentValueDiscounts	-19	usd
CY2022Q2	CELC	Lessee Finance Lease Liability Amount Representing Services LesseeFinanceLeaseLiabilityAmountRepresentingServices	-1252	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	156769	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	5379	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y9M18D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M24D
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.010	pure
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	48647	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	97204	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1446	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2893	usd
CY2022Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	11	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	25	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	20269	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	40538	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	70373	usd
	us-gaap	Lease Cost LeaseCost	140660	usd
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	70544	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	139429	usd
CY2022Q2	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	11	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	25	usd
CY2022Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1461	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2920	usd
CY2022Q2	CELC	Cash Paid For Operating And Finance Leases CashPaidForOperatingAndFinanceLeases	72016	usd
	CELC	Cash Paid For Operating And Finance Leases CashPaidForOperatingAndFinanceLeases	142374	usd
CY2022Q2	us-gaap	Contractual Obligation ContractualObligation	2600000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q2	CELC	Employee Service Share Based Compensation Non Vested Awards Compensation Cost Not Yet Recognized Remainder Of Fiscal Year EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear	2192203	usd
CY2022Q2	CELC	Employee Service Share Based Compensation Non Vested Awards Compensation Cost Not Yet Recognized Within Two Year EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedWithinTwoYear	3142793	usd
CY2022Q2	CELC	Employee Service Share Based Compensation Non Vested Awards Compensation Cost Not Yet Recognized Within Three Years EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedWithinThreeYears	2008832	usd
CY2022Q2	CELC	Employee Service Share Based Compensation Non Vested Awards Compensation Cost Not Yet Recognized Within Four Years EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedWithinFourYears	1091593	usd
CY2022Q2	CELC	Employee Service Share Based Compensation Non Vested Awards Compensation Cost Not Yet Recognized Within Five Years EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedWithinFiveYears	28373	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	8463794	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1519459	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	540317	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2275730	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	989415	usd
CY2021Q2	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	The Loan Agreement also contains certain events of default, warranties and covenants of the Company. In connection with each funding of the Term Loans, the Company is required to issue Innovatus a warrant (the “Warrants”) to purchase a number of shares of the Company’s stock equal to 2.5% of the principal amount of the relevant Term Loan funded divided by the exercise price, which will be based on the lower of (i) $14.40 per share or (ii) the volume weighted price per share of the Company’s stock for the five-trading day period ending on the last trading day immediately preceding the funding date of the Term C Loan
CY2021Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	26042	shares
CY2021Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	14.40
	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	The Term Loans will mature on the fifth anniversary of the initial funding date and will bear interest at a rate equal to sum of (a) the greater of (i) Prime Rate (as defined in the Loan Agreement) or (ii) 3.25%, plus (b) 5.70%
	CELC	Prepayment Fees Percentage Description PrepaymentFeesPercentageDescription	The Company has the option to prepay the loan at any time following the first anniversary of the loan closing, with tiered prepayment fees ranging from 0 – 2% based on when the prepayment would occur
CY2021Q2	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.20	pure
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	15000000	usd
CY2022Q2	CELC	Payment In Kind Interest Debt PaymentInKindInterestDebt	506000	usd
CY2022Q2	CELC	Notes Payable Final Fee NotesPayableFinalFee	675000	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	319359	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	850181	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	15011460	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5814750	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	7753000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2613250	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	16181000	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd

Files In Submission

Name	View Source	Status
0001493152-22-022400-index-headers.html	Edgar Link	pending
0001493152-22-022400-index.html	Edgar Link	pending
0001493152-22-022400.txt	Edgar Link	pending
0001493152-22-022400-xbrl.zip	Edgar Link	pending
celc-20220630.xsd	Edgar Link	pending
ex3-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
celc-20220630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
celc-20220630_lab.xml	Edgar Link	unprocessable
celc-20220630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
celc-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CELC
Celcuity Inc. Stock $celc

2022 Q3 Form 10-Q Financial Statement

#000149315222022400 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CELC Celcuity Inc. Stock $celc

2022 Q3 Form 10-Q Financial Statement

#000149315222022400 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CELC
Celcuity Inc. Stock $celc